Labcorp Holdings Inc. (LH)
Labcorp raises full-year forecasts on steady diagnostics demand
Labcorp raised its full-year profit and revenue forecast on Thursday after posting quarterly results above expectations as demand for ​diagnostic testing remained steady.
Wall Street's Insights Into Key Metrics Ahead of Labcorp (LH) Q1 Earnings
Beyond analysts' top-and-bottom-line estimates for Labcorp (LH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.
Labcorp Holdings (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
All You Need to Know About Labcorp (LH) Rating Upgrade to Buy
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should You Continue to Hold LH Stock in Your Portfolio?
Labcorp's expansion in specialty testing and efficiency gains support growth, but macroeconomic and competitive pressures could weigh on its outlook.
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Is Labcorp (LH) Down 4.6% Since Last Earnings Report?
Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Cinctive Capital Management LP Makes New Investment in Labcorp Holdings Inc. $LH
Cinctive Capital Management LP bought a new stake in shares of Labcorp Holdings Inc. (NYSE: LH) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 11,486 shares of the medical research company's stock, valued at approximately $3,297,000. Other hedge funds have also made
Labcorp Holdings Inc. $LH Stock Position Lifted by 8 Knots Management LLC
8 Knots Management LLC raised its stake in Labcorp Holdings Inc. (NYSE: LH) by 96.6% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 204,859 shares of the medical research company's stock after buying an additional 100,675 shares during the quarter. Labcorp
Glenmede Investment Management LP Sells 4,365 Shares of Labcorp Holdings Inc. $LH
Glenmede Investment Management LP cut its holdings in Labcorp Holdings Inc. (NYSE: LH) by 1.6% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 270,547 shares of the medical research company's stock after selling 4,365 shares during the quarter. Glenmede Investment Management
